Illumina Reports Preliminary Q4 Revenues of $260M | GenomeWeb

By a GenomeWeb staff reporter

This article has been updated from a previous version to include additional details from the company's presentation at the JP Morgan Healthcare Conference.

NEW YORK (GenomeWeb News) – Illumina on Tuesday announced preliminary fourth-quarter revenues of approximately $260 million and preliminary full-year 2010 revenue of approximately $901 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.